CRVL
CorVel Corporation
CRVL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over CRVL overall, supported by stronger modeled upside and lower modeled downside.
CRVL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CRVL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRVL.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CRVL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $76.95 | -11% |
| Current | 36x | $86.50 | — |
| Fair | 47x | $111 | +29% |
| Expensive | 59x | $141 | +63% |
Historical ranges are pointers, not guarantees.
CRVL has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CRVL Forward outlook
There aren't enough analyst estimates for CRVL to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
CRVL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.38 | +18% |
| Q2 2026 | $2.25 | +17% |
| Q1 2026 | $2.14 | +17% |
| Q4 2025 | $2.03 | +19% |
| Q3 2025 | $2.02 | +29% |
| Q2 2025 | $1.93 | +29% |
| Q1 2025 | $1.83 | +24% |
| Q4 2024 | $1.70 | +18% |
CRVL's earnings per share have climbed steadily: $2.38 over the past year, up 18% from the year before, and higher year over year for 22 quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over CRVL on earnings, with stronger typical year-over-year growth.
CRVL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.1M | +11% |
| Q2 2026 | $259.9M | +11% |
| Q1 2026 | $248.5M | +7.4% |
| Q4 2025 | $235.6M | +3.4% |
| Q3 2025 | $239.6M | +6.8% |
| Q2 2025 | $234.7M | +11% |
| Q1 2025 | $231.5M | +12% |
| Q4 2024 | $228M | +13% |
CRVL's revenue has grown year over year for 22 quarters in a row: $267M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.2 points |
| Q2 2026 | 17% | +1.6 points |
| Q1 2026 | 16% | +1.6 points |
| Q4 2025 | 14% | +0.2 points |
| Q3 2025 | 15% | +2.2 points |
| Q2 2025 | 15% | +1.8 points |
| Q1 2025 | 14% | +3.5 points |
| Q4 2024 | 14% | +2.5 points |
CRVL's operating margin was 17% last quarter, up 2.2 points from the same quarter a year ago, near the top of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over CRVL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over CRVL on profitability, with a higher operating margin.
CRVL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.3M | +92% |
| Q2 2026 | $43.1M | +8.9% |
| Q1 2026 | $20.3M | +42% |
| Q4 2025 | $35.2M | +9.5% |
| Q3 2025 | $15.3M | +23% |
| Q2 2025 | $39.5M | +21% |
| Q1 2025 | $14.3M | +174% |
| Q4 2024 | $32.1M | +43% |
CRVL has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CRVL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -238K shares |
| 1 year | -2% | -1M shares |
| 3 years | -2.6% | -1.3M shares |
| 5 years | -7.3% | -4M shares |
| Available history | -8.8% | -4.9M shares |
CRVL has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.6M |
| Q2 2026 | $22M |
| Q1 2026 | $20.2M |
| Q4 2025 | $13.6M |
| Q3 2025 | $12.8M |
| Q2 2025 | $9.6M |
| Q1 2025 | $9M |
| Q4 2024 | $9.5M |
CRVL spent $74M buying back its own shares over the past year, up 82% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
CRVL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
CRVL has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CRVL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.6 | Overbought |
| Stochastic | 85.6 | Overbought |
CRVL's weekly RSI is 77 (overbought) and its Stochastic is 86 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CRVL PE vs Financial Services Sector
| Metric | CRVL | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 13x | 179% above |
| PE % | 24 | 63 | 39 pts below |
CRVL is trading at 36x earnings, a 179% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over CRVL on valuation relative to its sector.
CRVL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.3 | 7.7% above |
| 20 week MA | $71.3 | 21% above |
| 50 week MA | $64.4 | 34% above |
| 100 week MA | $81.5 | 6.2% above |
| 200 week MA | $80.9 | 7% above |
CRVL has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CRVL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $34.7 | +21% |
| 2021 | $34.7 | $66.1 | +90% |
| 2022 | $66.1 | $48.0 | -27% |
| 2023 | $48.0 | $82.4 | +72% |
| 2024 | $82.4 | $113.7 | +38% |
| 2025 | $113.7 | $69.1 | -39% |
| 2026 YTD | $69.1 | $86.5 | +25% |
CRVL has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.